Shorts

Jihad Kaouk, MD, on getting started with single-port surgery

Christopher Weight, MD, MS, on determining candidates for bladder preservation

Petar Bajic, MD, on when physicians should refer patients with Peyronie disease

J. Welles Henderson, MD, FACOG, on managing mixed urinary incontinence

David Wise, MD, on the efficacy of pasritamig plus docetaxel in mCRPC

Amy E. Krambeck, MD, on 3- vs 2-lobe enucleation for BPH

Mohit Khera, MD, MBA, MPH, on why FDA TRT announcement is a “big win”

The UroOnc Minute: Dr. Alfonso Gómez de Liaño Lista on implications of KEYNOTE-B15

Jesse N. Mills, MD, on why urologists need to be at the forefront of treating low libido

Landon Trost, MD, on the significance of the FDA announcement on idiopathic hypogonadism

Mohit Khera, MD, MBA, MPH, reacts to FDA announcement on TRT and idiopathic hypogonadism

The Expert APProach: Melissa Kestler, DNP, FNP-BC, on working in a stone clinic

James R. Porter, MD, on the telementoring capabilities of the Hugo RAS

Pearls & Perspectives: Normalizing sexual wellness conversations

Jennifer Miles-Thomas, MD, discusses areas of opportunity for urology APPs

The Expert APProach: Preparing the Next Generation of APPs

Akanksha Mehta, MD, on counseling men on vasectomy safety

Jonathan Anker, MD, on bladder-sparing approach in patients with MIBC

Daniel J. George, MD, on PTEN loss and prostate cancer prognosis

Alexandra Drakaki, MD, on misdiagnosis of bladder cancer in women

Pearls & Perspectives: What is “normal” urination frequency?

Giulia Almiron da R. Soares on social media and urology recruitment

Jared S. Winoker, MD, on research comparing CVAC 2.0 vs FANS

James R. Porter, MD, discusses haptics and the Hugo RAS system

Matthias Saar, MD, outlines the rationale for the phase 2 INDUCTA trial in prostate cancer

Pearls & Perspectives: The trouble with voiding diaries

Is PCNL dead? with Ben H. Chew, MD, MSc, FRCSC

Alicia Morgans, MD, discusses cancer control with enzalutamide, apalutamide

Bogdana Schmidt, MD, MPH, on who could benefit most from ICI plus BCG in high-risk NMIBC

Neha Vapiwala, MD, explores the biggest prostate cancer takeaways from ASCO GU 2026